Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Tate & Lyle (TATE) by Numis
- Hold Croda International (CRDA) by Numis
- Sector Perform IG Group Holdings (IGG) by RBC Capital
- Buy Playtech (PTEC) by Numis
- Add Vesuvius (VSVS) by Numis
- Underweight Renishaw (RSW) by Barclays
- Equal Weight Fevertree Drinks (FEVR) by Barclays
- Buy The Gym Group (GYM) by Numis
- Buy Just Group (JUST) by Numis
- Underweight Rolls-Royce Holdings (RR.) by RBC Capital
- Sector Perform BHP Group Limited NPV (DI) (BHP) by RBC Capital
- Avoid Polymetal International (POLY) by Alan Oscroft in The Motley Fool
- Buy Legal & General Group (LGEN) by Cliff D'Arcy in The Motley Fool
- Risky Buy Vodafone Group (VOD) by Cliff D'Arcy in The Motley Fool
- Buy Marks & Spencer Group (MKS) by Jon Smith in The Motley Fool
- Buy Kingfisher (KGF) by Jon Smith in The Motley Fool
- Buy Aviva (AV.) by Jon Smith in The Motley Fool
- Buy Legal & General Group (LGEN) by Jon Smith in The Motley Fool
- Buy Wynnstay Group (WYN) by Hot Stock Rockets in ShareProphets
- Buy Concurrent Technologies (CNC) by John Choong in The Motley Fool
AstraZeneca (AZN)
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 1,014 open tips for this company
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Charlie Carman | – | 2023-02-02 13:30:00 02/02/2023 | – |
| – | Harshil Patel | – | 2023-02-02 07:00:00 02/02/2023 | – |
| – | Berenberg | – | 2023-02-01 18:00:00 01/02/2023 | – |
| – | Barclays | – | 2023-01-25 05:44:00 25/01/2023 | – |
| – | Charlie Carman | – | 2023-01-23 13:05:00 23/01/2023 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Charlie Carman | – | 2023-02-02 13:30:00 02/02/2023 | – |
| – | Harshil Patel | – | 2023-02-02 07:00:00 02/02/2023 | – |
| – | Berenberg | – | 2023-02-01 18:00:00 01/02/2023 | – |
| – | Barclays | – | 2023-01-25 05:44:00 25/01/2023 | – |
| – | Charlie Carman | – | 2023-01-23 13:05:00 23/01/2023 | – |